Discovery of a novel SOS1 inhibitor, AIG01012, targeting pan-KRAS mutant cancers

被引：0
|
作者：
Kim, Jihye
Park, Sejeong
Kim, Sunkyu
Lee, Sanghoon
Yoo, Kiwoong
Lee, Ho-Jeong
Kang, Jaewoo
Lee, Kwang-Ok
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3324
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3324
引用
收藏
页数：2
相关论文
共 30 条
  • [1] Novel Cereblon mediated bifunctional degraders of SOS1 for treatment of pan-KRAS mutant tumors
    Begovich, Kyle
    Schoolmeesters, Angela
    Rajapakse, Navin
    Kumar, Maneesh
    Shakya, Arvind
    Whitefield, Brandon
    Martinez-Terroba, Elena
    Pagadala, Nataraj
    Huang, Shenlin
    Chourasia, Aparajita H.
    Fung, Leah
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Probing and overcoming KRASG12C inhibitor resistance by combination with a pan-KRAS SOS1 inhibitor
    Hofmann, Marco H.
    Jurado, Sabine
    Gerlach, Daniel
    Koga, Takamasa
    Trapani, Francesca
    Gmachl, Michael
    Alpar, Donat
    Lieb, Simone
    Jeschko, Astrid
    Mitsudomi, Tetsuya
    Kraut, Norbert
    Petronczki, Mark P.
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell lines
    Plangger, Adelina
    Rath, Barbara
    Stickler, Sandra
    Hochmair, Maximilian
    Lang, Clemens
    Weigl, Lukas
    Funovics, Martin
    Hamilton, Gerhard
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [4] Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell lines
    Adelina Plangger
    Barbara Rath
    Sandra Stickler
    Maximilian Hochmair
    Clemens Lang
    Lukas Weigl
    Martin Funovics
    Gerhard Hamilton
    Discover Oncology, 13
  • [5] Discovery of RGT-018: A potent, selective and orally bioavailable SOS1 inhibitor for mutant KRAS-driven cancers
    Xiao, Fei
    Wang, Kailiang
    Wang, Xinjuan
    Li, Huijuan
    Hu, Zhilong
    Huang, Wei
    Ren, Xiaoming
    Feng, Teng
    Yao, Lili
    Lin, Jing
    Li, Chunlai
    Mei, Liufeng
    Zhang, Zhuanzhuan
    Liu, Yangyang
    Chen, Xi
    Zhu, Xiaotian
    Zhong, Wenge
    Xie, Zhi
    CANCER RESEARCH, 2023, 83 (07)
  • [6] A novel SOS1 inhibitor, HM99462 demonstrates antitumor activity against KRAS-mutant cancers
    Jung, Seung Hyun
    Choi, Jaeyul
    Park, Wongi
    Byun, Jooyun
    Lim, Semi
    Lee, Youngjoo
    Kim, Yu-Yon
    Park, Hyunjin
    Jeon, So-Ye
    Song, Taehun
    Choi, Kyungjin
    Kong, Tae-Yeon
    Kim, Heecheol
    Jang, Wook
    Lee, EunYoung
    Kim, Minhwa
    Ahn, Young Gil
    Kim, Young Hoon
    Suh, Kwee Hyun
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancer
    Alem, Diego
    Yang, Xinrui
    Beato, Francisca
    Sarcar, Bhaswati
    Tassielli, Alexandra F.
    Dai, Ruifan
    Hogenson, Tara L.
    Park, Margaret A.
    Jiang, Kun
    Cai, Jianfeng
    Yuan, Yu
    Fernandez-Zapico, Martin E.
    Tan, Aik Choon
    Fleming, Jason B.
    Xie, Hao
    MOLECULAR CARCINOGENESIS, 2023, 62 (07) : 1025 - 1037
  • [8] Discovery of RGT-018: A Potent, Selective, and Orally Bioavailable SOS1 Inhibitor for KRAS-Driven Cancers
    Xiao, Fei
    Wang, Kailiang
    Wang, Xinjuan
    Li, Huijuan
    Hu, Zhilong
    Ren, Xiaoming
    Huang, Wei
    Feng, Teng
    Yao, Lili
    Lin, Jing
    Li, Chunlai
    Zhang, Zhuanzhuan
    Mei, Liufeng
    Zhu, Xiaotian
    Zhong, Wenge
    Xie, Zhi
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (12) : 1703 - 1716
  • [9] Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor
    Huestis, Malcolm P.
    Dela Cruz, Darlene
    DiPasquale, Antonio G.
    Durk, Matthew R.
    Eigenbrot, Charles
    Gibbons, Paul
    Gobbi, Alberto
    Hunsaker, Thomas L.
    La, Hank
    Leung, Dennis H.
    Liu, Wendy
    Malek, Shiva
    Merchant, Mark
    Moffat, John G.
    Muli, Christine S.
    Orr, Christine J.
    Parr, Brendan T.
    Shanahan, Frances
    Sneeringer, Christopher J.
    Wang, Weiru
    Yen, Ivana
    Yin, Jianping
    Siu, Michael
    Rudolph, Joachim
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (05): : 791 - 797
  • [10] Discovery of novel indazole derivatives as SOS1 agonists that activate KRAS signaling
    Liu, Lu
    Song, Zhendong
    Fan, Guangjin
    Lou, Linlin
    Wang, Yuanxiang
    Zhang, Xiaolei
    Xiong, Xiao-Feng
    BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 93
123